Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Some aspects of the metabolism of glucose and of the non-esterified fatty acids in depressive patients

  • 14 Accesses

  • 9 Citations

This is a preview of subscription content, log in to check access.


  1. Armstrong, D. T., R. Steele, N. Altszuler, A. Dunn, J. S. Bishop, andR. C. de Bodo: Regulation of plasma free fatty acid turnover. Amer. J. Physiol.201, 9–15 (1961).

  2. Bogdonoff, M. D., E. H. Estes, S. J. Friedberg, andR. F. Klein: Fat mobilization in man. Ann. intern. Med.55, 328–338 (1961).

  3. — —,W. R. Harlan, D. L. Trout, andN. Kirshner: Metabolic and cardiovascular changes during a state of acute central nervous system arousal. J. clin. Endocr.20, 1333–1340 (1960a).

  4. —,A. M. Weissler, andF. L. Merritt: The effect of autonomic ganglionic blockade upon serum free fatty acid levels in man. J. clin. Invest.39, 959–965 (1960b).

  5. Cardon, P. V., andR. S. Gordon: Rapid increase of plasma unesterified fatty acids in man during fear. J. psychosom. Res.4, 5–9 (1959).

  6. Carlson, L. A., andL. Orö: The effect of nicotinic acid in the plasma free fatty acids. Acta med. scand.172, 641–645 (1962).

  7. Cooper, A. J., and K. M. G.Keddie: Hypotensive collapse and hypoglycaemia after mebanazine, a monoamine-oxidase inhibitor. Lancet1964 I, 1133–1135.

  8. Dole, V. P.: Fractionation of plasma nonesterified fatty acids. Proc. Soc. exp. Biol. (N. Y.)93, 532–533 (1956a).

  9. —: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest.35, 150–154 (1956b).

  10. Fredrickson, D. S., andR. S. Gordon: The metabolism of albumen-bound C14-labeled unesterified fatty acids in normal human subjects. J. clin. Invest.37, 1504–1515 (1958a).

  11. — —: Transport of fatty acids. Physiol. Rev.38, 585–630 (1958b).

  12. Freeman, H., andR. N. Zaborenke: Relation of changes in carbohydrate metabolism to psychotic states. Arch. Neurol. Psychiat. (Chic.)61, 569–576 (1949).

  13. Fröberg, S., S. O. Liljedahl, andL. Orö: Free fatty acids of plasma during insulin-induced hypoglycaemia in dog. Acta med. scand.176, 685–692 (1964).

  14. Gordon, R. S.: Unesterified fatty acid in human blood plasma, II. The transport function of unesterified fatty acid. J. clin. Invest.36, 810–815 (1957).

  15. —, andA. Cherkes: Unesterified fatty acid in human blood plasma. J. clin. Invest.35, 206–212 (1956).

  16. Hackfield, A. W.: Are physiologic disturbances related to the acute psychotic process in the mentally ill? Arch. Neurol. Psychiat. (Chic.)28, 883–890 (1932).

  17. Havel, R. J., andD. S. Fredrickson: The metabolism of chylomicra, I. The removal of palmitic acid—1-C14 labeled chylomicra from dog plasma. J. clin. Invest.35, 1025–1032 (1956).

  18. —, andA. Goldfien: The role of the sympathetic nervous system in the metabolism of free fatty acids. J. Lipid. Res.1, 102–108 (1959).

  19. Jeanrenaud, B.: Dynamic aspects of adipose tissue metabolism: a review. Metabolism10, 535–581 (1961).

  20. McCowan, P. K., andJ. H. Quastel: Bloodsugar studies in abnormal mental states. J. ment. Sci.77, 525–548 (1931).

  21. McFarland, R. A., andH. Goldstein: The biochemistry of manic-depressive psychosis. Amer. J. Psychiat.96, 21–58 (1939).

  22. Praag, H. M. van, andB. Leijnse: The influence of some antidepressives of the hydrazine type on the glucose metabolism in depressed patients. Clin. chim. Acta8, 466–475 (1963a).

  23. — —: Die Bedeutung der Psychopharmakologie für die klinische Psychiatrie. Systematik als notwendiger Ausgangspunkt. Nervenarzt34, 530–537 (1963b).

  24. Praag, H. M. van, andB. Leijnse: The xylose metabolism in depressed patients and its alterations under the influence of antidepressive hydrazines. Clin. chim. Acta11, 13–23 (1965a).

  25. — —: Depression, glucosetolerance, peripheral glucose uptake and their alterations under the influence of antidepressive drugs of the hydrazine type. Psychopharmacologia (Berl.)8, 67–78 (1965b).

  26. —,A. M. Uleman, andJ. C. Spitz: The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiat. Neurol. Neurochir. (Amst.)68, 329–346 (1965).

  27. Randle, P. J., P. B.Garland, C. N.Hales, and E. A.Newsholme: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet1963 I, 785–789.

  28. Reiter, P. J.: Über Störungen des Zuckerstoffwechsels bei Geisteskranken, insbesondere bei Syntonen. Z. ges. Neurol. Psychiat.107, 65–145 (1927).

  29. Shtacher, G., andE. Shafrir: Uptake and distribution of fatty acids in rat diaphragm and heart muscles in vitro. Arch. Biochem.106, 205–213 (1960).

  30. Somogyi, M.: Studies of arteriovenous differences in bloodsugar. J. biol. Chem.174, 189–200 (1948).

  31. Wickström, L., and K.Pettersson: Treatment of diabetics with mono-amine-oxydase inhibitors. Lancet1964 II, 995–997.

Download references

Author information

Additional information

This work was aided by grants from the Netherlands Organization for Pure Research (Z. W. O.).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van Praag, H.M., Leijnse, B. Some aspects of the metabolism of glucose and of the non-esterified fatty acids in depressive patients. Psychopharmacologia 9, 220–233 (1966). https://doi.org/10.1007/BF02198482

Download citation


  • Glucose
  • Depressive Patient